DENALI ADVISORS LLC

Position in JNJ — Johnson & Johnson

CIK 1142941 SAN DIEGO, CA

Position in JNJ

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$839,370

+$41,274 QoQ

Shares Held

3,305

+1.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#3,175

of 4,664 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 13% Shared 0% None 87%

Healthcare · as of Jun 30, 2026

DENALI ADVISORS LLC holds $21,250,231 across 5 Drug Manufacturers - General names. JNJ ranks #5 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,917	$15,493,038
2	NVS	Novartis AG	13,287	$2,082,338
3	GSK	GSK plc	28,680	$1,503,405
4	AZN	Astrazeneca PLC	7,025	$1,332,080
5	JNJ	Johnson & Johnson This page	3,305	$839,370

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$839,370	3,305	+1.2%	Shares	Sole	2026-08-10
2026-03-31	$798,096	3,265	-0.5%	Shares	Sole	2026-05-08
2025-12-31	$679,209	3,282	+1.5%	Shares	Sole	2026-02-03
2025-09-30	$599,462	3,233	-35.9%	Shares	Sole	2025-11-07
2025-06-30	$770,471	5,044	-1.0%	Shares	Sole	2025-07-30
2025-03-31	$845,120	5,096	-0.6%	Shares	Sole	2025-05-05
2024-12-31	$741,611	5,128	+1.3%	Shares	Sole	2025-02-04
2024-09-30	$820,185	5,061	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.